CellCept

Active ingredient
Mycophenolatmofetil
Pharma Company
Roche Pharma AG/ Roche Deutschland Holding GmbH
Total Number of Doctors1
n/a
Total Number of Patients2
600 patients
Total minimum fees planned3
1,200,000.00 €

Observational Studies including CellCept

Drug No. of doctors1 No. of patients2 Payment per patient3
Myfenax vs. CellCept n/a n/a 250.00 € pro Patient
CellCept, Advagraf, Prograf, Simulect, Prednisolon-Präparate n/a 600 2,000.00 € in 5 Jahren, für jeden abgeschlossenen ordnungsgemäß dokumentierten Fall
CellCept n/a n/a 90.00 € 90,00€ - Monatsdokumentation, unterschiedliche Aufwandsentschädigung z.b. Pat. nach Transplantation eine Therapie beginnen 123,50€ s.Vertrag

Background

Independent journalism needs independent funding

Others can write stories. We want to reveal. We are the first investigative newsroom in Germany, which is independent, ad-free, and non-profit.

For us, the core of journalism means uncovering injustice and shortcomings in society. That’s why we investigate corruption in the health system, politicians abusing their power, and an elite that believes that rules are for the others.

To do our job, we need people, who support us. We ask you, too, to become a member and enable the work of 16 investigative journalists at CORRECTIV.

We are convinced that without independent and critical media, democracy fought for and won by our ancestors, cannot survive for long.